Brii Biosciences Limited Stock Buy Hold or Sell Recommendation
| BRIBF Stock | USD 0.13 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Brii Biosciences Limited is 'Strong Sell'. Macroaxis provides Brii Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BRIBF positions.
Check out Brii Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Brii and provide practical buy, sell, or hold advice based on investors' constraints. Brii Biosciences Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Brii |
Execute Brii Biosciences Buy or Sell Advice
The Brii recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Brii Biosciences Limited. Macroaxis does not own or have any residual interests in Brii Biosciences Limited or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Brii Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Brii Biosciences Trading Alerts and Improvement Suggestions
| Brii Biosciences generated a negative expected return over the last 90 days | |
| Brii Biosciences has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (4.16 B) with profit before overhead, payroll, taxes, and interest of 92.54 M. | |
| Brii Biosciences Limited has accumulated about 3.22 B in cash with (879.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from gurufocus.com: ADAG Stock Surges Amidst Biotech Sector Growth |
Brii Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Brii Biosciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Brii Biosciences' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Brii pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Brii Biosciences Volatility Alert
At this time Brii Biosciences Limited exhibits very low volatility. Brii Biosciences Limited is a potential penny stock. Although Brii Biosciences may be in fact a good instrument to invest, many penny pink sheets are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Brii Biosciences Limited. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Brii instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Brii Biosciences Fundamentals Vs Peers
Comparing Brii Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Brii Biosciences' direct or indirect competition across all of the common fundamentals between Brii Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Brii Biosciences or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Brii Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Brii Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Brii Biosciences to competition |
| Fundamentals | Brii Biosciences | Peer Average |
| Return On Equity | -5.34 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Operating Margin | (10.33) % | (5.51) % |
| Current Valuation | 305.78 M | 16.62 B |
| Shares Outstanding | 723.35 M | 571.82 M |
| Shares Owned By Insiders | 5.41 % | 10.09 % |
| Shares Owned By Institutions | 53.10 % | 39.21 % |
| Price To Book | 0.95 X | 9.51 X |
| Price To Sales | 10.64 X | 11.42 X |
| Gross Profit | 92.54 M | 27.38 B |
| EBITDA | (4.18 B) | 3.9 B |
| Net Income | (4.16 B) | 570.98 M |
| Cash And Equivalents | 3.22 B | 2.7 B |
| Cash Per Share | 4.45 X | 5.01 X |
| Total Debt | 17.47 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 10.68 X | 2.16 X |
| Book Value Per Share | 4.43 X | 1.93 K |
| Cash Flow From Operations | (879.46 M) | 971.22 M |
| Earnings Per Share | (1.42) X | 3.12 X |
| Number Of Employees | 123 | 18.84 K |
| Market Capitalization | 941.75 M | 19.03 B |
| Total Asset | 3.61 B | 29.47 B |
| Z Score | 28.5 | 8.72 |
| Net Asset | 3.61 B |
Brii Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Brii . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Brii Biosciences Buy or Sell Advice
When is the right time to buy or sell Brii Biosciences Limited? Buying financial instruments such as Brii Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Brii Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Picks Thematic Idea Now
Macroaxis Picks
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Brii Pink Sheet
Brii Biosciences financial ratios help investors to determine whether Brii Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brii with respect to the benefits of owning Brii Biosciences security.